Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1990 Mar;29(3):339–346. doi: 10.1111/j.1365-2125.1990.tb03645.x

Development of tolerance to nifedipine in patients with stable angina pectoris.

S Y Martsevich 1, V I Metelitsa 1, D O Rumiantsev 1, V K Piotrovskii 1, I D Slastnikova 1, L V Egorov 1, V A Vygodin 1
PMCID: PMC1380135  PMID: 2310657

Abstract

1. The possibility of development of tolerance to the anti-ischaemic and anti-anginal effects of nifedipine during sustained administration for 2 months was studied in 15 patients with stable angina pectoris by means of repeated exercise tests on a treadmill. 2. After acute administration of nifedipine (20-30 mg) substantial anti-ischaemic and anti-anginal effects lasted for at least 4 h in all patients. 3. During sustained nifedipine treatment with a dose schedule which provided continuous anti-ischaemic effect during a day (mean daily dose 82.7 +/- 6.0 mg, range 60-120 mg) a substantial attenuation of this effect was registered. The duration of the anti-ischaemic effect was 5.4 +/- 0.3 h after acute administration, decreasing significantly to 3.6 +/- 0.4 h during sustained administration. 4. The attenuation of the nifedipine effect was not associated with worsening of the patients' condition. 5. Plasma concentrations of nifedipine and its metabolite were similar after acute administration and during sustained treatment. Protein binding of nifedipine also remained constant during the study. 6. There was marked interindividual variation in the degree of attenuation of the nifedipine effect during sustained administration. In five patients nearly complete loss of nifedipine efficacy was registered. Eight to ten days after stopping regular administration of nifedipine only partial restoration of nifedipine effect was observed. 7. We conclude that during sustained nifedipine administration tolerance to its anti-ischaemic, anti-anginal and circulatory effects develops in a substantial number of patients with stable angina pectoris.

Full text

PDF
339

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crake T., Quyyumi A. A., Wright C., Mockus L., Fox K. M. Treatment of angina pectoris with nifedipine: a double blind comparison of nifedipine and slow-release nifedipine alone and in combination with atenolol. Br Heart J. 1987 Dec;58(6):617–620. doi: 10.1136/hrt.58.6.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Eldridge J. E., Burdick D. C., Jones R. H., Hossack K. F. Comparison of nitroglycerin patches and nifedipine. J Cardiovasc Pharmacol. 1987 Sep;10(3):315–319. doi: 10.1097/00005344-198709000-00010. [DOI] [PubMed] [Google Scholar]
  3. Jariwalla A. G., Anderson E. G. Production of ischaemic cardiac pain by nifedipine. Br Med J. 1978 May 6;1(6121):1181–1182. doi: 10.1136/bmj.1.6121.1181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kleinbloesem C. H., van Brummelen P., Faber H., Breimer D. D. Pharmacokinetics and hemodynamic effects of long-term nifedipine treatment in hypertensive patients. J Cardiovasc Pharmacol. 1987 Feb;9(2):202–208. doi: 10.1097/00005344-198702000-00012. [DOI] [PubMed] [Google Scholar]
  5. McCans J. L. Diltiazem dose responses in sustained therapy for stable angina pectoris. Can J Cardiol. 1986 Nov-Dec;2(6):332–337. [PubMed] [Google Scholar]
  6. Metelitsa V. I., Martsevich SYu, Piotrovskii V. K., Ryabokon O. S., Blagodatskikh S. V. New transdermal and transmucosal nitroglycerin delivery systems in patients with ischaemic heart disease. Eur J Clin Pharmacol. 1987;32(1):5–10. doi: 10.1007/BF00609950. [DOI] [PubMed] [Google Scholar]
  7. Meyer J. S., Nance M., Walker M., Zetusky W. J., Dowell R. E., Jr Migraine and cluster headache treatment with calcium antagonists supports a vascular pathogenesis. Headache. 1985 Oct;25(7):358–367. doi: 10.1111/j.1526-4610.1985.hed2507358.x. [DOI] [PubMed] [Google Scholar]
  8. Mueller H. S., Chahine R. A. Interim report of multicenter double-blind, placebo-controlled studies of nifedipine in chronic stable angina. Am J Med. 1981 Oct;71(4):645–657. doi: 10.1016/0002-9343(81)90229-1. [DOI] [PubMed] [Google Scholar]
  9. Nazarenko V. A., Nikolenko S. A. Metod izucheniia farmakodinamiki antianginal'nykh preparatov s pomoshch'iu povtornykh nagruzovhnykh testov. Kardiologiia. 1981 Jan;21(1):64–68. [PubMed] [Google Scholar]
  10. Parker J. O., Fung H. L., Ruggirello D., Stone J. A. Tolerance to isosorbide dinitrate: rate of development and reversal. Circulation. 1983 Nov;68(5):1074–1080. doi: 10.1161/01.cir.68.5.1074. [DOI] [PubMed] [Google Scholar]
  11. Stone P. H., Muller J. E., Turi Z. G., Geltman E., Jaffe A. S., Braunwald E. Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm. Am Heart J. 1983 Oct;106(4 Pt 1):644–652. doi: 10.1016/0002-8703(83)90081-9. [DOI] [PubMed] [Google Scholar]
  12. Vetrovec G. W., Parker V. E., Cole S., Procacci P. M., Tabatznik B., Terry R. Nifedipine gastrointestinal therapeutic system in stable angina pectoris. Results of a multicenter open-label crossover comparison with standard nifedipine. Am J Med. 1987 Dec 21;83(6B):24–29. doi: 10.1016/0002-9343(87)90633-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES